Abiopharma

🔍 MALONE JOHN C (Director)

Company: Liberty Capital Corp/NV (GLIBK)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Sold 13,200 shares of Call option (obligation to sell) at $41.2049 per share (Derivative)
  Date: 2026-08-21 | Code: E | equity_swap_involved: 1 | shares_owned_after: 147,200.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Sold 13,200 shares of Put option (right to sell) at $30.15 per share (Derivative)
  Date: 2026-08-21 | Code: X | equity_swap_involved: 1 | shares_owned_after: 147,200.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Sold 13,200 shares of Call option (obligation to sell) at $41.2049 per share (Derivative)
  Date: 2026-08-24 | Code: E | equity_swap_involved: 1 | shares_owned_after: 134,000.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Sold 13,200 shares of Put option (right to sell) at $30.15 per share (Derivative)
  Date: 2026-08-24 | Code: X | equity_swap_involved: 1 | shares_owned_after: 134,000.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Sold 13,400 shares of Call option (obligation to sell) at $41.2049 per share (Derivative)
  Date: 2026-08-25 | Code: E | equity_swap_involved: 1 | shares_owned_after: 120,600.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Sold 13,400 shares of Put option (right to sell) at $30.15 per share (Derivative)
  Date: 2026-08-25 | Code: X | equity_swap_involved: 1 | shares_owned_after: 120,600.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: As previously disclosed by the Reporting Person, on July 15, 2025, the Reporting Person was automatically deemed to have entered into a "zero-cost collar" arrangement with respect to 200,000 shares of the Issuer's Series C GCI Group Common Stock (the "Collar"), pursuant to which he wrote European call options and purchased European put options referencing shares of Series C GCI Group Common Stock. Only one of the options can be in the money on the expiration date, at which time the in-the-money options will be exercised, and the other options will expire. If neither the put options nor the call options are in the money on the expiration date, both the put and call options will expire. The Collar will be settled in cash unless the Reporting Person elects physical settlement.
• F2: The Collar is divided into 15 components, the first 5 of which are with respect to 13,200 shares of Series C GCI Group Common Stock and the last 10 of which are with respect to 13,400 shares, maturing on sequential trading days over the period beginning on August 18, 2026 and ending on September 8, 2026.
• F3: On August 21, 2026, the fourth component of the Collar settled in cash and the Reporting Person received a cash amount of $60,984. On the same date, the related call option expired unexercised.
• F4: On August 24, 2026, the fifth component of the Collar settled in cash and the Reporting Person received a cash amount of $57,684. On the same date, the related call option expired unexercised.
• F5: On August 25, 2026, the sixth component of the Collar settled in cash and the Reporting Person received a cash amount of $50,652. On the same date, the related call option expired unexercised.